Results 61 to 70 of about 59,802 (286)

Hexokinase inhibition using D-Mannoheptulose enhances oncolytic newcastle disease virus-mediated killing of breast cancer cells

open access: yesCancer Cell International, 2020
Background Most cancer cells exhibit increased glycolysis and use this metabolic pathway cell growth and proliferation. Targeting cancer cells’ metabolism is a promising strategy in inhibiting cancer cell progression. We used D-Mannoheptulose, a specific
Ahmed Ghdhban Al-Ziaydi   +4 more
doaj   +1 more source

Human hexokinase: multiple mechanisms of G6P inhibition

open access: yes, 2001
Human hexokinase I catalyzes the first step in glycolysis, playing a key role in the energy metabolism of brain tissue. The chapters included in this thesis focus on structure-function relationships of hexokinase I.
Liu, Xiaofeng
core   +1 more source

Hexokinase and carnitine palmitoyltransferase activities in flight muscles of grasshopper Valanga nigricornis(burm.) [PDF]

open access: yes, 1983
1. The activities of hexokinase and carnitine palmitoyltransferase (CPT) activities were assayed in flight muscle mitochondria of Valanga nigricornis. 2. Kinetic analysis of the enzyme activities yielded the following information: for hexokinase, its Km (
Lee, C. W., Tan, C. H.
core   +1 more source

A Neutrophil Membrane‐Encapsulated Pd/hCeO2 Nanoformulation for Alleviating Age‐Dependent Perioperative Neurocognitive Disorders

open access: yesAdvanced Science, EarlyView.
This study reports a neutrophil membrane‐encapsulated Pd/hCeO2 nanozyme (PCN) for targeted treatment of perioperative neurocognitive disorders (PND) in aged mice. PCN inhibits glycolysis‐driven microglial activation and neuroinflammation, improves mitochondrial respiration, and maintains blood‐brain barrier integrity and synaptic function, ultimately ...
Lili Huang   +17 more
wiley   +1 more source

Cellular acidosis triggers human MondoA transcriptional activity by driving mitochondrial ATP production

open access: yeseLife, 2019
Human MondoA requires glucose as well as other modulatory signals to function in transcription. One such signal is acidosis, which increases MondoA activity and also drives a protective gene signature in breast cancer.
Blake R Wilde   +3 more
doaj   +1 more source

Mitochondrial VDAC and hexokinase together modulate plant programmed cell death

open access: yes, 2013
The voltage-dependent anion channel (VDAC) and mitochondrially located hexokinase have been implicated both in pathways leading to cell death on the one hand, and immortalization in tumor formation on the other.
Udayakumar, M.   +4 more
core   +1 more source

Hexokinase 2 as oncotarget

open access: yesOncotarget, 2013
It is well established that cancer cells differ from most somatic adult cells by their high rate of aerobic glycolysis despite oxidative phosphorylation. This distinct property of cancer cells is often used for tumor imaging in vivo following the administration of the labeled glucose analog, fluoro deoxy glucose (FDG).
Krushna C, Patra, Nissim, Hay
openaire   +2 more sources

Decoding Biomolecular Phase Separation: From Physiological Roles to Pathological Mechanisms and Therapeutic Biomaterials Design

open access: yesAdvanced Science, EarlyView.
This review systematically elaborates on the mechanisms underlying physiological regulation and pathological dysregulation of biomolecular phase separation. It also summarizes advances in phase‑separation‑targeted therapeutic strategies and the design of functional biomaterials inspired by this process.
Jiawei Zhu   +5 more
wiley   +1 more source

In vitro synthesis of rat brain hexokinase.

open access: yes, 1985
Hexokinase (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1) has been synthesized in the rabbit reticulocyte lysate system directed by poly(A)+ mRNA isolated from rat brain. Identification of the in vitro synthesis product as hexokinase was based on its
Wilson, J E, Kozak, L P, Pittler, S J
core   +1 more source

Yoda1‐Functionalized Nanozymes Coordinate Piezo1 Activation and Mitochondrial Protection to Reprogram the Diabetic Osteoimmune Micromilieu and Promote Vascularized Bone Repair

open access: yesAdvanced Science, EarlyView.
Diabetic bone defects remain a critical clinical challenge. A 3D‐printed BCPG‐MF@Y scaffold, embedding Yoda1‐functionalized manganese dioxide‐ferritin nanozymes, scavenges mtROS, suppresses the cGAS–STING pathway, and reverses cellular senescence, while Yoda1 activates Piezo1 to direct BMSCs fate to synergistically reprogram the osteoimmune ...
Qing‐Song Deng   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy